Park Ha Biological Technology Co. vs Senestech
Park Ha Biological Technology Co. and Senestech are similar in size: $2.5m and $2.2m of revenue in their latest fiscal years. Senestech grew faster (19.6% against 6.0%). Senestech kept more of each dollar of sales as profit: a net margin of -287.4% against -965.0%. Park Ha Biological Technology Co. carries less debt relative to equity (0.0% against 2.2%).
| Latest fiscal year | Park Ha Biological Technology Co.BYAH, 2025 | SenestechSNES, 2025 |
|---|---|---|
| Revenue | $2.5m | $2.2m |
| Revenue growth | 6.0% | 19.6% |
| Net income | −$24.4m | −$6.4m |
| Operating margin | -956.5% | -292.9% |
| Net margin | -965.0% | -287.4% |
| Return on equity | — | -105.7% |
| Free cash flow | −$2,973 | −$5.9m |
| Cash | $3.8m | $7.6m |
| Total debt | $0 | $206,000 |
| Debt to equity | 0.0% | 2.2% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | 23 |
| Market value | $1.1m | $6.8m |
| Price vs our value range | — | — |
| Moat score | — | 22 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 47 buys, 2 sales |